Ganoderma lucidum (Reishi mushroom) for cancer treatment.
- 2016-04-05
- Meta-Analysis
- The Cochrane database of systematic reviews 2019(1)
- Xingzhong Jin
- Julieta Ruiz Beguerie
- Daniel Man-Yeun Sze
- Godfrey C F Chan
- PubMed: 27045603
- DOI: 10.1002/14651858.cd007731.pub3
- High evidence
- Clinical
G. lucidum simultaneously increases the percentage of CD8 by 2.02% (95% CI 0.21% to 3.84%, P = 0.03)
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes